Structure Therapeutics, Inc. Sponsored ADR
(NASDAQ: GPCR)
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
32.850
+1.230
(+3.89%)
Range
30.940 - 33.550
(8.44%)
Open
31.610
Previous Close
31.620
Bid Price
23.230
Bid Volume
9
Ask Price
26.800
Ask Volume
9
Volume
1,096,685
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
